Skip to main content

Table 2 The comparison between treatment groups and standard group in the duration of oxygen-support and CoV RNA clearance time

From: Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2

  Standard care (n = 12) Interferon (n = 44) LPV/r plus interferon (n = 67) Total patients (n = 123) P-value
Oxygen-support duration 13 (7, 24) 13 (8, 16) 11 (7, 22) 12 (8, 19) 0.98
Viral clearance 9 (5, 15) 11 (8, 17) 14 (8, 20) 12 (7, 18) 0.33
  1. Data are median (IQR)